Society for Pediatric Pathology
Menu

2020 SPP Spring Meeting
February 28 - March 1, 2020
Los Angeles, California, USA

Registration now open! 

NEW THIS SPRING:  Poster Blitz!

In response to your feedback to have time with the authors at their posters, we are introducing a Poster Blitz. The Blitz session is a rapid series of brief presentations where you have the opportunity to advertise your poster(s). You will be given 60 SECONDS to “sell” your scientific content and convince other participants to visit your poster.  This session will be paired with a cocktail reception and provide dedicated time for presenters to be at their posters.

Committee Meetings - February 28, 2020

8:00 a.m. – 10:00 a.m.

Executive Committee Meeting (closed)

9:00 a.m. – 12:00 p.m.

Education Committee (closed)

10:00 a.m. – 11:30 a.m.

Finance Committee Meeting (open)

11:30 a.m. – 1:00 p.m.

PDP Editorial Board Meeting with Lunch (by invitation)

1:00 p.m. – 2:00 p.m.

Membership Committee (open)

1:00 p.m. – 2:00 p.m.

Informatics & Communication Committee (open)

1:00 p.m. – 2:00 p.m.

Practice Committee (open)

1:00 p.m. – 2:30 p.m.

Research & Awards Committee (closed)

2:00 p.m. – 3:00 p.m.

Fellowship Committee (open)

2:00 p.m. – 3:00 p.m.

Perinatal Committee (open)

2:00 p.m. – 3:30 p.m.

Publications Committee (open)

2:30 p.m. – 4:00 p.m.

Slide Survey Subcommittee Working Meeting (closed)

4:00 p.m. – 6:00 p.m.

Board of Directors Meeting (by invitation)

 Scientific and Educational Sessions – February 29 and March 1, 2020

Click here for the preliminary schedule of the 2020 SPP Spring Meeting

Farber-Landing Lecture: Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis, but with Ongoing Challenges in Management, David M. Parham, MD, Chief of Anatomic Pathology, Children’s Hospital Los Angeles

At the end of this session, participants should be able to:

  • Describe the concepts and history behind the current standard of rhabdomyosarcoma diagnosis
  • Recognize morphological and biological variants of rhabdomyosarcoma
  • Recite the current therapeutic standards for rhabdomyosarcoma and how they are affected by modern genetic testing

 Symposia: Pediatric Bone Lesions; Practical Approach

  • Radiologic-Pathologic Correlation, What Pathologists Need To Know, Miriam A Bredella, MD

At the end of this session, participants should be able to:

  • Interpret specific imaging findings that indicate malignancy in pediatric bone tumors
  • Identify imaging findings of benign pediatric bone lesions
  • Diagnose non-neoplastic conditions that can mimic neoplasia
  • General Approach to Bone Pathology, Gunnlaugur Petur Nielsen, MD

At the end of this session, participants should be able to:

  • Recite the radiographic features of common bone tumors
  • Recognize the histologic features of more common bone tumors
  • Describe how immunohistochemistry may help with diagnosing selected tumors
  • Challenges Encountered at Interpreting Core Biopsies and Intraoperative Frozen Sections, Gunnlaugur Petur Nielsen, MD

At the end of this session, participants should be able to:

  • Acknowledge the purpose of needle core frozen section diagnosis
  • Identify the limitation of frozen section needle core biopsies
  • Describe the application of frozen sections on resection specimens
  • Benign Bone Lesions and Reactive Conditions Mimicking Neoplasia, Practical Approach, Alyaa Al-Ibraheemi, MD

At the end of this session, participants should be able to:

  • Comprehend commonly encountered pediatric bone lesions with focus on benign and non-neoplastic conditions mimicking neoplasia
  • Grasp the key histologic features necessary for the differential diagnosis of pediatric bone lesions
  • Acknowledge the importance of interdisciplinary approach when working up bone lesions
  • What Surgeons Want to Know from Pathology Reports and Frozen Sections Diagnosis, Mark Gebhardt, MD

At the end of this session, participants should be able to:

  • Recite the main points of a bone tumor pathology report (e.g., diagnosis, grade, neoplasm type)
  • Describe what the surgeon expects from an intra-operative frozen section (benign versus malignant, need for more tissue, special processing) and will see examples of difficult diagnoses and the approach to establishing the best diagnosis (second opinions, joint surgeon-pathologist review of histology
  • List what the surgeon needs to know following a tumor resection (e.g., margin, percent necrosis, frozen section data)

Workshop Sessions:

A. Year 1/3: Discovering Cancer Predisposition in Children, John Hicks, MD & Kyle Kurek, MD -- NEW!

At the end of this session, participants should be able to:

  • List unusual presentations, disease processes, lesions and/or neoplasms that are associated with cancer predisposition syndromes in pediatrics
  • Describe clinical, pathologic and outcome features of cancer predisposition syndromes
  • Describe the various methods necessary to identify the genetic alterations in cancer predisposition syndromes
  • Describe the pathophysiology and role of pathologist in recognition and diagnosis of syndromes
  • Describe challenges associated with molecular diagnosis and the associated challenges: 1) describe genetic variants, somatic vs germline mutations; 2) describe interpretation of variants of unknown significance; and 3) describe patient consent issues in molecular testing

B. Year 2/3: What Can the Placenta Tell Us? Debra S. Heller, MD & Rebecca N. Baergen, MD

At the end of this session, participants should be able to:

  • Diagnose placental lesions with a risk of recurrence in future pregnancies
  • Diagnose placental lesions associated with neurologic injury and stillbirth
  • Recite the terminology used in placental pathology including the Amsterdam Placental Workshop Guidelines

C. Year 3/3: WHO Classification of Tumors of the Central Nervous System Pediatric Tumors,  Alexander Judkins, MD, Cynthia Hawkins, MD, Mariarita Santi, MD  -- Last year of workshop

At the end of this session, participants should be able to:

  • Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of medulloblastoma
  • Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of medulloblastoma
  • Apply immunohistochemical and molecular techniques to determine medulloblastoma molecular subgroup
  • Appreciate the clinical relevance of molecular subgrouping and TP53 mutation status in medulloblastoma
  • Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma)
  • Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma).
  • Distinguish AT/RT lacking histological features of rhabdoid differentiation from other pediatric CNS embryonal tumors on the basis of immunohistochemistry and/or molecular analysis of SMARCB1/INI1 and/or SMARCA4/BRG1.
  • Using their molecular profile, distinguish C19MC-altered embryonal tumors from other pediatric embryonal CNS tumors.
  • Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric glial tumors
  • Approach the diagnosis of pediatric glial brain tumors using a combination of morphology and molecular diagnostic techniques
  • Distinguish the BRAF mutated glial tumors from the Histone-3 mutated tumors and extrapolate the prognostic implications.
  • Separate the molecular profile of supratentorial ependymomas from the infratentorial
  • Integrate morphologic and molecular results into a comprehensive pathology report

D. Year 1/3: Hirschsprung Disease: Diagnostic, Intra-operative, and Post-operative, Raj P. Kapur, MD, PhD & Miguel Reyes-Mugica, MD  -- NEW!

At the end of this session, participants should be able to: 

  • List two H&E, one enzyme histochemical, and two immunohistochemical findings found in the majority of rectal biopsies from patients with Hirschsprung disease and recognize the diagnostic features and limitations of each
  • List three H&E features of transition zone and recognize their diagnostic characteristics
  • Advise a surgeon how to proceed with pullthrough resection based on either identification of ganglion cells in a leveling biopsy or features of transition zone in a circumferential section from the proximal resection margin
  • Conduct a comprehensive gross and microscopic examination of a Hirschsprung resection specimen to document clinically relevant anatomic pathology

E. Year 2/3: Role of Bias in Pediatric Pathology: Preventing Errors and Enhancing Patient Safety One Child at a Time, Vinay Prasad, MD, MPH & Kathleen  Nicol, MD -- American Board of Pathology approved Patient Safety Course!

At the end of this session, participants should be able to: 

  • Identify human factors that contribute to errors and patient safety
  • Create a culture of safety within their laboratory areas
  • Implement methods and tools for avoiding medical errors
  • Identify diagnostic errors specific to pediatric pathology and pediatric laboratory medicine
  • Describe systems thinking and the effect of the system on patient safety
  • Describe epidemiology of error in laboratory medicine
  • Recite the fundamentals of quality improvement

F. Year 3/3: Bone Dysplasias: A Systematic Diagnostic Approach,  Linda Ernst, MD & Peter Nikkels, MD  -- Last year of workshop

At the end of this session, participants should be able to:

  • Describe the diagnostic histological aspects of some common skeletal dysplasia’s recognizable at birth
  • Describe the diagnostic features of the X-rays of several common skeletal dysplasia’s recognizable at birth
  • Recognize the limitations of histology to diagnose a skeletal dysplasia
  • Use a diagnostic scheme to diagnose the more common skeletal dysplasia’s recognizable at birth

Education Information

The 2020 SPP Meeting in Los Angeles, CA, will offer 14.5 CME credits and 7.0 SAM eligible credits. 

The Society for Pediatric Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The SPP designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™ and 7 ABP Part II Self-Assessment Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*All participants will have 90 days from the end of the meeting to claim credits.*

Exhibits & Sponsorships

The exhibits will be held in the Doubletree Los Angeles Downtown. To encourage a good flow of traffic throughout the room, poster presentations will be displayed near, but not in, the exhibit area due to ACCME restrictions. Coffee will be served only in the exhibit area during morning and afternoon dedicated program breaks.

The market you need to reach will be in attendance and will include decision makers in the field of pediatric pathology and the related specialty of perinatal pathology. Exhibit space is limited for this meeting and will be granted on a first come, first served basis. Only completed applications with full payment included will be guaranteed space.

We hope you will be among those who take advantage of this outstanding marketing opportunity and we look forward to the early return of your completed application.

Click here for the Exhibitor Prospectus.

Hotel

All events are located at the Doubletree by Hilton Hotel Los Angeles Downtown unless otherwise noted

You will find the information for your online reservation link below. If you have questions or need help with the link, please do not hesitate to ask. We appreciate your business and look forward to a successful event.  

Last Day to Book: Wednesday, February 5, 2020

Hotel(s) offering your special group rate: Doubletree by Hilton Hotel Los Angeles Downtown ~ $199.00 USD per night

Book your group rate for SPP 2020 Spring Meeting

 Travel

Delta Air Lines is offering special discounted* airfares for attendees traveling to Los Angeles, California. 

Discounts vary, depending on the class of ticket purchased, up to 10% off the fare. 
*Please note the following:

  • Not all fare codes are eligible for a discount; fare rules determine eligibility
  • Discounts vary, depending on the class of ticket purchased, and apply to round trip travel only.
  • Not valid with any other discounts, certificates, coupons or promotional offers.
  • Name changes on the ticket are permitted at $200 USD/$200 CAD on select fares.

Delta Airlines Discount

Taking advantage of this discount is easy! Just click the “Advanced Search” link on www.delta.com and enter NMTVL in the box that says “Meeting Event Code.” If your flight qualifies for a discount, it will automatically be applied to your search results. We suggest using this discount to book your SPP flight.

Meeting Event Code: NMTVL
SkyBonus Points Member Number: US0084894

Transportation

Carey is the world's leading provider of chauffeured services and ground transportation logistics management. Carey features a world-class fleet of late-model executive and luxury vehicles, best-in-class professional chauffeurs, and a full portfoloio of specialized transportation logistics. 

SPP is managed by The Kellen Company. Kellen is an Association Management Company with a portfolio of Trade Associations and Professional Societies. Kellen has partnered with Avis Budget Group as their primary car rental vendors and has extended their special discounts with SPP. Through this partnership, our company will be receiving significant savings and benefits, in addition to negotiated rates and outstanding personalized service. You can enroll in either Avis or Budget, or both!

First, create an Avis or Budget account. For this you'll need your driver's license and credit card ready. You can rent a car without an account, but you'll lose the benefit of skipping the counter. 

If you already have a profile, add Kellen's discount codes, D619101 for AVIS Wizard and D958401 for Budget Fastbreak, to your account to receive the rates and benefits Kellen has already negotiated on your behalf. Negotiated insurances are not included.

Photography Disclaimer

When you enter an SPP event or program, you enter an area where photography, audio, and video recording may occur. By entering the event premises, you consent to interview(s), photography, audio recording, video recording and its/their release, publication, exhibition, or reproduction to be used for news, web casts, promotional purposes, telecasts, advertising, inclusion on websites, social media, or any other purpose by SPP. Images, photos and/or videos may be used to promote similar SPP events in the future, highlight the event and exhibit the capabilities of SPP. You release SPP, its officers and employees, and each and all persons involved from any liability connected with the taking, recording, digitizing, or publication and use of interviews, photographs, computer images, video and/or or sound recordings. By entering the event premises, you waive all rights you may have to any claims for payment or royalties in connection with any use, exhibition, streaming, web casting, televising, or other publication of these materials, regardless of the purpose or sponsoring of such use, exhibiting, broadcasting, web casting, or other publication irrespective of whether a fee for admission or sponsorship is charged. You also waive any right to inspect or approve any photo, video, or audio recording taken by SPP or the person or entity designated to do so by SPP. You have been fully informed of your consent, waiver of liability, and release before entering the event.

Top